Chronic myeloid leukemia (CML) is characterized by the presence of the BCR-ABL1 fusion gene, which encodes a constitutive active tyrosine kinase considered to be the pathogenic driver capable of initiating and maintaining the disease. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.